Hypercholesterolemia and microvascular dysfunction: interventional strategies
Open Access
- 18 November 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Inflammation
- Vol. 7 (1), 54
- https://doi.org/10.1186/1476-9255-7-54
Abstract
Hypercholesterolemia is defined as excessively high plasma cholesterol levels, and is a strong risk factor for many negative cardiovascular events. Total cholesterol levels above 200 mg/dl have repeatedly been correlated as an independent risk factor for development of peripheral vascular (PVD) and coronary artery disease (CAD), and considerable attention has been directed toward evaluating mechanisms by which hypercholesterolemia may impact vascular outcomes; these include both results of direct cholesterol lowering therapies and alternative interventions for improving vascular function. With specific relevance to the microcirculation, it has been clearly demonstrated that evolution of hypercholesterolemia is associated with endothelial cell dysfunction, a near-complete abrogation in vascular nitric oxide bioavailability, elevated oxidant stress, and the creation of a strongly pro-inflammatory condition; symptoms which can culminate in profound impairments/alterations to vascular reactivity. Effective interventional treatments can be challenging as certain genetic risk factors simply cannot be ignored. However, some hypercholesterolemia treatment options that have become widely used, including pharmaceutical therapies which can decrease circulating cholesterol by preventing either its formation in the liver or its absorption in the intestine, also have pleiotropic effects with can directly improve peripheral vascular outcomes. While physical activity is known to decrease PVD/CAD risk factors, including obesity, psychological stress, impaired glycemic control, and hypertension, this will also increase circulating levels of high density lipoprotein and improving both cardiac and vascular function. This review will provide an overview of the mechanistic consequences of the predominant pharmaceutical interventions and chronic exercise to treat hypercholesterolemia through their impacts on chronic sub-acute inflammation, oxidative stress, and microvascular structure/function relationships.Keywords
This publication has 119 references indexed in Scilit:
- Differential Impact of Familial Hypercholesterolemia and Combined Hyperlipidemia on Vascular Wall and Network Remodeling in MiceMicrocirculation, 2010
- The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talkJournal Of Physiology-London, 2009
- Chronic hypoxia enhances 15-lipoxygenase-mediated vasorelaxation in rabbit arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Characterization of endothelial thromboxane receptors in rabbit aortaProstaglandins & Other Lipid Mediators, 2008
- Increased Arachidonic Acid‐Induced Thromboxane Generation Impairs Skeletal Muscle Arteriolar Dilation with Genetic DyslipidemiaMicrocirculation, 2008
- Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient miceFree Radical Biology & Medicine, 2008
- Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatinBritish Journal of Clinical Pharmacology, 2008
- Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemiaFree Radical Biology & Medicine, 2007
- Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arteriolesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseJournal of Hepatology, 2005